Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 0.58% today. In the last week its performance is -0.53%, and -12.86% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 313.94, so today’s gain of 0.58% is a significant step towards its target price. The GAP today is therefore 0.35%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 53.48 B, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 91.70%.
At the current price of 252.81, it has a dividend yield of *TBA, and its target price is 313.94. This is with a profit margin of 30.20%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 15.85, as well as a forward P/E of 11.2.
With a current EPS of 15.95, and a forecasted EPS growth for next year at 10.23%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 27.40%. For the next five years EPS growth is projected to be 6.34%.
Performance for the year is -4.34%. Since its IPO date on 9/17/1991, the total performance to date is -10.85%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 1242567, while its average volume is 1544.29. Whilst the total gain today was 0.58%, it did have a day high of -14.28%.
Volatility for this week has been at 1.62%, and 1.73% for the month. The 52-week low for Biogen Inc., BIIB has been 13.36%, while the 52-week-high has reached -24.23%.
Looking at its return of investments, which is 21.00%, and its return on assets is 15.90%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 41.60%. With a sales growth of 3.10% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.52, and has a current ratio of 2.3 and 2 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.5, and the P/S is 4.64, along with a P/B of 4.75. Meanwhile it has a p/cash of 18.57.